What does Envista do?

Envista makes and sells products that dentists and dental specialists use to treat patients. Its range covers dental implants, braces and clear aligners, dental imaging systems, and everyday supplies such as filling materials, cements, and disinfecting wipes. It sells in the United States, China, and other countries.

What is Envista's fair value?

On an owner-earnings DCF, Envista's most-likely fair value is about $32, versus a recent price near $23. A margin-of-safety estimate, not a price target. Analysis, not advice.

Healthcare · Medical Instruments & Supplies · NVST

What Envista Does & How It Makes Money (NVST)

Updated October 2026 · reflects Envista's latest reported financials

Dental products maker: implants, orthodontics, imaging, and dental consumables. It earns revenue by selling dental implants, orthodontic products, imaging equipment and software, and repeat-purchase consumables to dental offices, clinics, hospitals, labs, and specialists.

Envista's story, moat and numbers — in a 3-minute visual book.

Explore Envista on TacticScale →

How Envista makes money

It earns revenue by selling dental implants, orthodontic products, imaging equipment and software, and repeat-purchase consumables to dental offices, clinics, hospitals, labs, and specialists. The business is split into two segments: Specialty Products & Technologies, and Equipment & Consumables.

What Envista does

Envista Holdings is a dental products company incorporated in 2018 and headquartered in Brea, California. Its Specialty Products & Technologies segment covers dental implant systems, guided surgery, biomaterials, and prosthetics under brands such as Nobel Biocare, Alpha-Bio Tec, and Implant Direct. The segment also includes orthodontics, including brackets, wires, clear aligners, and digital treatments, under Ormco, Damon, Spark, and Insignia. The Equipment & Consumables segment supplies dental offices, clinics, and hospitals with digital imaging systems and software (Dexis, DTX Studio), endodontic systems (Sybron Endo), and restorative materials and bonding agents (Kerr, Pentron, Optibond). It also sells infection prevention products (Metrex, CaviWipes). Much of this is recurring consumables sold alongside capital equipment, and the company sells in the U.S., China, and other international markets.

Products & services

Nobel Biocare dental implants
Ormco / Damon orthodontic brackets
Spark clear aligners
Dexis digital imaging systems
DTX Studio software
Kerr restorative materials

What is Envista worth?

On an owner-earnings DCF, Envista's most-likely value is about $32 versus a recent price near $23 (39% below fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~$19) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.

Verdict: Fairly priced — no edge

Owner-earnings fair value · recent price ≈ $23

Fair value (most likely)

$32

Range

$26–$47

No-growth floor

$19

Price

~$23

Price sits in the normal range — fair value isn't actionable here; it earns its keep only when price drops below the no-growth floor, or runs to roughly double the optimistic case.

Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →

Sector Healthcare Industry Medical Instruments & Supplies HQ United States Ticker NVST Official site

Related companies

Enovis (ENOV) · DENTSPLY SIRONA (XRAY) · Align Technology (ALGN) · Integra LifeSciences (IART) · Viatris (VTRS)

Understand Envista in 3 minutes →